Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-056334
Filing Date
2013-11-04
Accepted
2013-11-04 13:40:13
Documents
1
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 rrd393960.html 4  
1 rrd393960.xml 4 6257
  Complete submission text file 0001181431-13-056334.txt   8373
Mailing Address 3550 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3550 JOHN HOPKINS COURT SAN DIEGO CA 92121 858 431-8500
VERENIUM CORP (Issuer) CIK: 0001049210 (see all company filings)

EIN.: 223297375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address 605 THIRD AVENUE NEW YORK NY 10158
Business Address 605 THIRD AVENUE NEW YORK NY 10158 212-476-5926
Athyrium Opportunities Fund (B) LP (Reporting) CIK: 0001540542 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-29173 | Film No.: 131188478

Mailing Address 605 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE, 22ND FLOOR NEW YORK NY 10158 212.402.6925
Athyrium Opportunities Fund (A) LP (Reporting) CIK: 0001589714 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-29173 | Film No.: 131188479